Mori Y - Search Results

1

FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease.

Mori Y, Dendl K, Cardinale J, Kratochwil C, Giesel FL, Haberkorn U. Mori Y, et al. Radiology. 2023 Feb;306(2):e220749. doi: 10.1148/radiol.220749. Epub 2023 Jan 3. Radiology. 2023. PMID: 36594838 Review.

2

One-pot and one-step automated radio-synthesis of [¹⁸F]AlF-FAPI-74 using a multi purpose synthesizer: a proof-of-concept experiment.

Naka S, Watabe T, Lindner T, Cardinale J, Kurimoto K, Moore M, Tatsumi M, Mori Y, Shimosegawa E, Valla F Jr, Kato H, Giesel FL. Naka S, et al. Among authors: mori y. EJNMMI Radiopharm Chem. 2021 Aug 21;6(1):28. doi: 10.1186/s41181-021-00142-z. EJNMMI Radiopharm Chem. 2021. PMID: 34420105 Free PMC article.

3

A Role of Non-FDG Tracers in Lung Cancer?

Novruzov E, Mori Y, Antke C, Dabir M, Schmitt D, Kratochwil C, Koerber SA, Haberkorn U, Giesel FL. Novruzov E, et al. Among authors: mori y. Semin Nucl Med. 2022 Nov;52(6):720-733. doi: 10.1053/j.semnuclmed.2022.05.004. Epub 2022 Jul 6. Semin Nucl Med. 2022. PMID: 35803770 Review.

4

Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies.

Dendl K, Koerber SA, Tamburini K, Mori Y, Cardinale J, Haberkorn U, Giesel FL. Dendl K, et al. Among authors: mori y. Semin Nucl Med. 2022 Sep;52(5):628-634. doi: 10.1053/j.semnuclmed.2022.04.002. Epub 2022 Jul 13. Semin Nucl Med. 2022. PMID: 35842334 Review.

5

Three-Time-Point PET Analysis of ⁶⁸Ga-FAPI-46 in a Variety of Cancers.

Naeimi M, Choyke PL, Dendl K, Mori Y, Staudinger F, Watabe T, Koerber SA, Röhrich M, Debus J, Kratochwil C, Haberkorn U, Giesel FL. Naeimi M, et al. Among authors: mori y. J Nucl Med. 2023 Apr;64(4):618-622. doi: 10.2967/jnumed.122.264941. Epub 2022 Nov 10. J Nucl Med. 2023. PMID: 36357183 Free article.

6

Unique [¹⁸F]FDG PET imaging pattern of drug-induced acute generalized exanthematous pustulosis within the SCAR-spectrum.

Novruzov E, Schmitt D, Mori Y, Kirchner J, Kobbe G, Reifenberger J, Mamlins E, Antke C, Giesel FL. Novruzov E, et al. Among authors: mori y. Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1532-1533. doi: 10.1007/s00259-022-06060-9. Epub 2022 Dec 9. Eur J Nucl Med Mol Imaging. 2023. PMID: 36484789 Free PMC article. No abstract available.

7

[Breakeven Analysis for Imaging Devices: Basic Introduction with Presentation of a User-Friendly Tool for in-clinic Calculation Using PET/CT as an Example].

Zippel C, Antke C, Mori Y, Sombetzki A, Antoch G, Giesel FL. Zippel C, et al. Among authors: mori y. Nuklearmedizin. 2023 Jun;62(3):185-191. doi: 10.1055/a-2036-7694. Epub 2023 Apr 5. Nuklearmedizin. 2023. PMID: 37019151 German.

8

Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical Translation.

Mori Y, Kratochwil C, Haberkorn U, Giesel FL. Mori Y, et al. PET Clin. 2023 Jul;18(3):419-428. doi: 10.1016/j.cpet.2023.02.007. Epub 2023 Apr 6. PET Clin. 2023. PMID: 37030981 Review.

9

⁶⁸Ga- or ¹⁸F-FAPI PET/CT-what it can and cannot.

Mori Y, Haberkorn U, Giesel FL. Mori Y, et al. Eur Radiol. 2023 Nov;33(11):7877-7878. doi: 10.1007/s00330-023-09715-9. Epub 2023 May 12. Eur Radiol. 2023. PMID: 37171487 Free PMC article. No abstract available.

10

Initial Evaluation of [¹⁸F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions.

Watabe T, Naka S, Tatsumi M, Kamiya T, Kimura T, Shintani Y, Abe K, Miyake T, Shimazu K, Kobayashi S, Kurokawa Y, Eguchi H, Doki Y, Inohara H, Kato H, Mori Y, Cardinale J, Giesel FL. Watabe T, et al. Among authors: mori y. J Nucl Med. 2023 Aug;64(8):1225-1231. doi: 10.2967/jnumed.123.265486. Epub 2023 Jun 2. J Nucl Med. 2023. PMID: 37268427 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,666 results

Search Page